Feed 6461.TWO
64
Intech Biopharm Corporation
6461.TWO · TWO
$15.90 -0.31% (-$0.05)
1M +3.13%
Market Cap $2.9B
P/E Ratio -
Div. Yield -
ROE 40.53%
Bulios Fair Price
$21.92
37.9% upside
Trenutna cena
$15.9
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica 6461.TWO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Valuation
37 /100
Fair P/B 2.59x
P/S 26.54x
EV/FFO N/A
Growth
86 /100
Growing Book val. growth 2.19%
Rev. growth 65.67%
FCF growth N/A
Profitability
0 /100
Weak Net margin 361.80%
Op. margin 338.99%
FCF margin 395.38%
Quality
1 /100
Poor ROE 40.53%
ROA 16.55%
Asset turnover 0.05x
Debt
41 /100
Moderate Current ratio 1.66x
Int. coverage -10.87x
Debt/Equity 1.08x
Stability
31 /100
Unstable Rev. volatility 83.13%
EPS volatility 2.42%
Profitable years 0
Vprašajte StockBota o 6461.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wei Hsiu Wu
Employees
96
Headquarters
Taipei